- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x AEW: 1-(3-amino-2-methylbenzyl)-4-hexylpyridin-2(1H)-one(Non-covalent)
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.2: 25 residues within 4Å:- Chain A: G.39, I.40, A.41, S.45, I.46, R.66, S.70, I.91, D.92, V.93, S.119, I.120, A.121, I.146, T.171, T.172, Y.173, K.190, A.216, G.217, P.218, I.219, T.221, S.223
- Ligands: AEW.1
23 PLIP interactions:23 interactions with chain A- Hydrophobic interactions: A:I.46, A:Y.173, A:Y.173, A:A.216
- Hydrogen bonds: A:G.39, A:G.39, A:A.41, A:I.46, A:R.66, A:S.70, A:D.92, A:V.93, A:S.119, A:A.121, A:K.190, A:I.219, A:I.219, A:T.221, A:T.221, A:S.223, A:S.223
- Salt bridges: A:R.66
- pi-Cation interactions: A:R.66
NDP.4: 25 residues within 4Å:- Chain B: G.39, I.40, A.41, S.45, I.46, R.66, S.70, I.91, D.92, V.93, S.119, I.120, A.121, I.146, T.171, T.172, Y.173, K.190, A.216, G.217, P.218, I.219, T.221, S.223
- Ligands: AEW.3
22 PLIP interactions:22 interactions with chain B- Hydrophobic interactions: B:I.46, B:Y.173, B:Y.173, B:A.216
- Hydrogen bonds: B:G.39, B:I.46, B:R.66, B:R.66, B:K.67, B:S.70, B:D.92, B:V.93, B:S.119, B:A.121, B:K.190, B:I.219, B:I.219, B:T.221, B:S.223, B:S.223
- Salt bridges: B:R.66
- pi-Cation interactions: B:R.66
NDP.7: 27 residues within 4Å:- Chain C: G.39, I.40, A.41, N.42, S.45, I.46, R.66, S.70, I.91, D.92, V.93, S.119, I.120, A.121, I.146, T.171, T.172, Y.173, K.190, A.216, G.217, P.218, I.219, T.221, L.222, S.223
- Ligands: AEW.6
22 PLIP interactions:22 interactions with chain C- Hydrophobic interactions: C:I.46, C:Y.173, C:Y.173, C:A.216
- Hydrogen bonds: C:G.39, C:I.46, C:R.66, C:S.70, C:D.92, C:V.93, C:S.119, C:S.119, C:K.190, C:I.219, C:I.219, C:T.221, C:T.221, C:L.222, C:S.223, C:S.223
- Salt bridges: C:R.66
- pi-Cation interactions: C:R.66
NDP.9: 25 residues within 4Å:- Chain D: G.39, I.40, A.41, S.45, I.46, R.66, S.70, I.91, D.92, V.93, S.119, I.120, A.121, I.146, T.171, T.172, Y.173, K.190, A.216, G.217, P.218, I.219, T.221, S.223
- Ligands: AEW.8
20 PLIP interactions:20 interactions with chain D- Hydrophobic interactions: D:Y.173, D:Y.173
- Hydrogen bonds: D:G.39, D:A.41, D:I.46, D:R.66, D:S.70, D:D.92, D:V.93, D:S.119, D:S.119, D:A.121, D:K.190, D:I.219, D:I.219, D:T.221, D:S.223, D:S.223
- Salt bridges: D:R.66
- pi-Cation interactions: D:R.66
- 1 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schiebel, J. et al., Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (Acp) Reductase Inhibitor. J.Biol.Chem. (2014)
- Release Date
- 2014-04-16
- Peptides
- ENOYL-ACP REDUCTASE MOLECULE ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.10 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x AEW: 1-(3-amino-2-methylbenzyl)-4-hexylpyridin-2(1H)-one(Non-covalent)
- 4 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 1 x SO4: SULFATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schiebel, J. et al., Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (Acp) Reductase Inhibitor. J.Biol.Chem. (2014)
- Release Date
- 2014-04-16
- Peptides
- ENOYL-ACP REDUCTASE MOLECULE ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADPH]: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D